---
$id: https://graph.org.ai/products/commodity/51302310
$type: Product
source: UNSPSC
code: "51302310"
title: "Democonazole"
class: "51302300"
classTitle: "Antifungal imidazoles"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Democonazole

**UNSPSC Code**: 51302310
**Class**: [Antifungal imidazoles](Antifungal imidazoles.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent with the molecular formula C19H15Cl3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z4E7E087J, chemically known as (e)-1-(2,4-dichloro-beta-(2-(p-chlorophenoxy)ethoxy)styryl)imidazole but generally known as democonazole, which bears US NIH Compound Identifier 3033986. European Medicines Agency schedules Democonazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06969MIG. The term DEMOCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). DEMOCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule democonazole under HS 29332990 and SITC 51573. As of Q4 2014, DEMOCONAZOLE remains the US FDA Preferred Term for this commodity. Democonazole bears US NLM identifiers UMLS ID C0629429 and NCI Concept Code C78038. SMILES: CLC1C(C(=C\N2CCNC2)/OCCOC2CCC(CL)CC2)CCC(CL)C1.

